Examkin

Question

Difficulty: MediumPediatric Endocrine Disorders

A 5-day-old female neonate is evaluated in the nursery for persistent tachycardia, irritability, and poor weight gain. She was born at 38 weeks gestation via spontaneous vaginal delivery. Her current weight is 2.8 kg, down from a birth weight of 3.2 kg. Vital signs show a temperature of 37.5∘C37.5^\circ\text{C} (99.5∘F99.5^\circ\text{F}), heart rate of 192/min192/\text{min}, and respiratory rate of 52/min52/\text{min}. Physical examination reveals a restless infant with warm, flushed skin and a wide-eyed stare. The mother has a history of Graves disease and was treated with a total thyroidectomy four years ago; she takes levothyroxine daily and maintained normal thyroid hormone levels throughout her pregnancy. Laboratory studies of the infant demonstrate a thyroid-stimulating hormone (TSH) level of <0.01 μU/mL<0.01\ \mu\text{U/mL} and an elevated free thyroxine (T4) level. Which of the following is the most likely underlying mechanism for this neonate's clinical presentation?

  1. A
    Endogenous neonatal production of thyroid-stimulating immunoglobulins
  2. B
    Passage of maternal thyroid-stimulating hormone across the placenta
  3. C
    Inadequate maternal iodine intake during the third trimester
  4. D
    Transplacental transfer of maternal exogenous levothyroxine
  5. Transplacental passage of maternal thyrotropin receptor antibodiesAnswer

Answer

Transplacental passage of maternal thyrotropin receptor antibodies
The correct answer identifies the transplacental passage of maternal thyrotropin receptor antibodies (TRAb). Graves disease is an autoimmune condition driven by IgG antibodies that stimulate the TSH receptor. Because IgG antibodies cross the placenta, a fetus can be subjected to continuous thyroid stimulation, resulting in neonatal thyrotoxicosis (neonatal Graves disease). Crucially, these antibodies can remain elevated in the maternal circulation for years after definitive treatment with radioactive iodine or total thyroidectomy, even if the mother is clinically euthyroid while on daily levothyroxine replacement.

Step-by-Step Solution

1
Analyze the neonate's clinical presentation and laboratory findings.
The infant exhibits classic signs of hypermetabolism (tachycardia, irritability, excessive weight loss, warm skin) confirmed by a suppressed TSH and elevated free T4, diagnostic of neonatal thyrotoxicosis.
Establishing the functional thyroid status of the infant directs the search for the underlying etiology.
2
Evaluate the maternal history for a source of the neonatal endocrine dysfunction.
The mother has a history of Graves disease. Although she had a total thyroidectomy and is euthyroid on levothyroxine, her autoimmune condition implies she likely still produces thyrotropin receptor antibodies (TRAb).
Maternal history is the most critical factor in diagnosing neonatal thyroid disorders, as maternal factors often dictate neonatal outcomes.
3
Determine the pathophysiological link between the mother's immune status and the infant's thyrotoxicosis.
Maternal TRAb are IgG antibodies, which freely cross the placenta. These antibodies stimulate the fetal and neonatal thyroid gland, leading to the overproduction of thyroid hormones.
Understanding placental transfer dynamics (IgG crosses, TSH does not, T4 crosses poorly) is required to identify the correct mechanism.

Key Concept

Neonatal thyrotoxicosis (neonatal Graves disease) is caused by the transplacental passage of maternal thyrotropin receptor antibodies (IgG), which can persist in the maternal circulation for years even after definitive treatment (e.g., thyroidectomy or radioactive iodine) for Graves disease.

Alternative Method

Recognize the classic 'trap' presentation: a mother with a history of Graves disease who has been 'cured' via surgery or ablation but still harbors circulating IgG antibodies. The infant's thyrotoxicosis usually resolves spontaneously over a few months as the maternal IgG antibodies are degraded by the infant.
Estimated Time:1m 15s
Rate this question

Topics

Pediatric Endocrine Disorders

More questions from this topic